Understanding hesitancy with revealed preferences across COVID-19 vaccine types

Simple item page
dc.citation.articleNumber13293
dc.citation.journalTitleScientific Reports
dc.citation.volumeNumber12
dc.contributor.authorKutasi, Kristóf
dc.contributor.authorKoltai, Júlia
dc.contributor.authorSzabó-Morvai, Ágnes
dc.contributor.authorRöst, Gergely
dc.contributor.authorKarsai, Márton
dc.contributor.authorBiró, Péter
dc.contributor.authorLengyel, Balázs
dc.date.accessioned2022-08-09T15:43:17Z
dc.date.available2022-08-09T15:43:17Z
dc.date.issued2022
dc.description.abstractMany countries have secured larger quantities of COVID-19 vaccines than their population is willing to take. The abundance and the large variety of vaccines created not only an unprecedented intensity of vaccine related public discourse, but also a historical moment to understand vaccine hesitancy better. Yet, the heterogeneity of hesitancy by vaccine types has been neglected in the existing literature so far. We address this problem by analysing the acceptance and the assessment of five vaccine types. We use information collected with a nationally representative survey at the end of the third wave of the COVID-19 pandemic in Hungary. During the vaccination campaign, individuals could reject the assigned vaccine to wait for a more preferred alternative that enables us to quantify revealed preferences across vaccine types. We find that hesitancy is heterogenous by vaccine types and is driven by individuals’ trusted source of information. Believers of conspiracy theories are more likely to evaluate the mRNA vaccines (Pfizer and Moderna) unacceptable. Those who follow the advice of politicians are more likely to evaluate vector-based (AstraZeneca and Sputnik) or whole-virus vaccines (Sinopharm) acceptable. We argue that the greater selection of available vaccine types and the free choice of the individual are desirable conditions to increase the vaccination rate in societies.
dc.identifier.citationKutasi, Kristóf, Koltai, Júlia, Szabó-Morvai, Ágnes, et al.. "Understanding hesitancy with revealed preferences across COVID-19 vaccine types." <i>Scientific Reports,</i> 12, (2022) Springer Nature: https://doi.org/10.1038/s41598-022-15633-5.
dc.identifier.doihttps://doi.org/10.1038/s41598-022-15633-5
dc.identifier.urihttps://hdl.handle.net/1911/113079
dc.language.isoeng
dc.publisherSpringer Nature
dc.rightsThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.titleUnderstanding hesitancy with revealed preferences across COVID-19 vaccine types
dc.typeJournal article
dc.type.dcmiText
dc.type.publicationpublisher version
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
s41598-022-15633-5.pdf
Size:
1.47 MB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Rice Coronavirus Research